Thiostrepton: A Novel Therapeutic Drug Candidate for Infection.

Molecules

Molecular Mechanisms of Antibiotics, Division of Life Science, Research Institute of Life Science, Gyeongsang National University, Jinju 52828, Korea.

Published: December 2019

is a rapid-growing, multidrug-resistant, non-tuberculous mycobacterial species responsible for a variety of human infections, such as cutaneous and pulmonary infections. infections are very difficult to eradicate due to the natural and acquired multidrug resistance profiles of . Thus, there is an urgent need for the development of effective drugs or regimens against infections. Here, we report the activity of a US Food and Drug Administration approved drug, thiostrepton, against . We found that thiostrepton significantly inhibited the growth of wild-type strains, subspecies, clinical isolates, and drug-resistant mutants in vitro and in macrophages. In addition, treatment of macrophages with thiostrepton significantly decreased proinflammatory cytokine production in a dose-dependent manner, suggesting an inhibitory effect of thiostrepton on inflammation induced during infection. We further showed that thiostrepton exhibits antimicrobial effects in vivo using a zebrafish model of infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943738PMC
http://dx.doi.org/10.3390/molecules24244511DOI Listing

Publication Analysis

Top Keywords

thiostrepton
6
thiostrepton novel
4
novel therapeutic
4
therapeutic drug
4
drug candidate
4
candidate infection
4
infection rapid-growing
4
rapid-growing multidrug-resistant
4
multidrug-resistant non-tuberculous
4
non-tuberculous mycobacterial
4

Similar Publications

Optimizing genome editing efficiency in via a CRISPR/Cas9n-mediated editing system.

Appl Environ Microbiol

January 2025

State Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, College of Life Sciences, Hubei University, Wuhan, China.

is an important bioresource to produce various antibacterial natural products, however, the time-consuming and labor-intensive genome editing toolkits hindered the construction and application of engineered strains, and this study aimed to establish an efficient CRISPR/Cas9n genome editing system in . Initially, the CRISPR/Cas9-mediated editing tool was employed to replace those awkward genome editing tools that relied on homologous recombination, while the off-target Cas9 exhibited high toxicity to Sf01. Therefore, the nickase mutation D10A, high-fidelity mutations including N497A, R661A, Q695A, and Q926A, and thiostrepton-induced promotor P were incorporated into the Cas9 expression cassette, which reduced its toxicity.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. Due to the poor therapeutic efficacy of CRC treatments and poor prognosis of the disease, effective treatment strategies are urgently needed. As long-term proteotoxic stress is a major cause of cell death, agents that induce proteotoxic stress offer a promising strategy for cancer intervention.

View Article and Find Full Text PDF

Thiostrepton (TST) is a naturally occurring oligopeptide antibiotic with a demonstrated capacity to antagonize a broad spectrum of Gram-positive bacteria. It has been utilized as a safe antimicrobial agent in veterinary medicine. Despite its therapeutic potential, the clinical application of TST has been constrained by its poor solubility and bioavailability.

View Article and Find Full Text PDF

Light inducible gene expression system for Streptomyces.

Sci Rep

October 2024

Life Science Research Center, College of Bioresource Sciences, Nihon University, 1866 Kameino, Fujisawa, 252-0880, Japan.

The LitR/CarH family comprises adenosyl B-based photosensory transcriptional regulators that control light-inducible carotenoid production in nonphototrophic bacteria. In this study, we established a blue-green light-inducible hyperexpression system using LitR and its partner ECF-type sigma factor LitS in streptomycin-producing Streptomyces griseus NBRC 13350. The constructed multiple-copy number plasmid, pLit19, carried five genetic elements: pIJ101rep, the thiostrepton resistance gene, litR, litS, and σ-recognized light-inducible crtE promoter.

View Article and Find Full Text PDF

Complete sequences of pIJ101-based Streptomyces-Escherichia coli shuttle vectors.

Access Microbiol

October 2024

Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Big Rapids, MI 49307, USA.

High-copy-number plasmids are indispensable tools for gene overexpression studies in prokaryotes to engineer pathways or probe phenotypes of interest. The development of genetic tools for the industrially relevant Actinobacteria is of special interest, given their utility in producing keratolytic enzymes and biologically active natural products. Within the Actinobacteria, shuttle vectors based on the SCP2* and pIJ101 incompatibility groups are widely employed for molecular cloning and gene expression studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!